搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Ralstonia solanacearum Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP849068RAR
CSB-EP849068RAR
CSB-BP849068RAR
CSB-MP849068RAR
CSB-EP849068RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Ribose-phosphate pyrophosphokinase (prs) CSB-YP849069RAR
CSB-EP849069RAR
CSB-BP849069RAR
CSB-MP849069RAR
CSB-EP849069RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Octanoyltransferase (lipB) CSB-YP849070RAR
CSB-EP849070RAR
CSB-BP849070RAR
CSB-MP849070RAR
CSB-EP849070RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Isocitrate dehydrogenase kinase/phosphatase (aceK), partial CSB-YP849071RAR
CSB-EP849071RAR
CSB-BP849071RAR
CSB-MP849071RAR
CSB-EP849071RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS), partial CSB-YP849072RAR
CSB-EP849072RAR
CSB-BP849072RAR
CSB-MP849072RAR
CSB-EP849072RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Protease HtpX homolog (htpX), partial CSB-YP849073RAR1
CSB-EP849073RAR1
CSB-BP849073RAR1
CSB-MP849073RAR1
CSB-EP849073RAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum ATP-dependent protease subunit HslV (hslV) CSB-YP849074RAR
CSB-EP849074RAR
CSB-BP849074RAR
CSB-MP849074RAR
CSB-EP849074RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Ribonuclease P protein component (rnpA) CSB-YP849075LPY
CSB-EP849075LPY
CSB-BP849075LPY
CSB-MP849075LPY
CSB-EP849075LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Phosphoserine aminotransferase (serC) CSB-YP849076LPY
CSB-EP849076LPY
CSB-BP849076LPY
CSB-MP849076LPY
CSB-EP849076LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Catalase (kat) CSB-YP849077LPY
CSB-EP849077LPY
CSB-BP849077LPY
CSB-MP849077LPY
CSB-EP849077LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a UPF0133 protein lmo2703 (lmo2703) CSB-YP849078LPY
CSB-EP849078LPY
CSB-BP849078LPY
CSB-MP849078LPY
CSB-EP849078LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Elongation factor G (fusA), partial CSB-YP849079LPY
CSB-EP849079LPY
CSB-BP849079LPY
CSB-MP849079LPY
CSB-EP849079LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a 30S ribosomal protein S5 (rpsE) CSB-YP849080LPY
CSB-EP849080LPY
CSB-BP849080LPY
CSB-MP849080LPY
CSB-EP849080LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a tRNA pseudouridine synthase A (truA) CSB-YP849081LPY
CSB-EP849081LPY
CSB-BP849081LPY
CSB-MP849081LPY
CSB-EP849081LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Homoserine kinase (thrB) CSB-YP849082LPY
CSB-EP849082LPY
CSB-BP849082LPY
CSB-MP849082LPY
CSB-EP849082LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a ATP synthase epsilon chain (atpC) CSB-YP849083LPY
CSB-EP849083LPY
CSB-BP849083LPY
CSB-MP849083LPY
CSB-EP849083LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a UvrABC system protein B (uvrB), partial CSB-YP849084LPY
CSB-EP849084LPY
CSB-BP849084LPY
CSB-MP849084LPY
CSB-EP849084LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Putative sporulation transcription regulator WhiA (whiA) CSB-YP849085LPY
CSB-EP849085LPY
CSB-BP849085LPY
CSB-MP849085LPY
CSB-EP849085LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Methionine import ATP-binding protein MetN 2 (metN2) CSB-YP849086LPY
CSB-EP849086LPY
CSB-BP849086LPY
CSB-MP849086LPY
CSB-EP849086LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a UPF0754 membrane protein lmo2224 (lmo2224), partial CSB-YP849087LPY1
CSB-EP849087LPY1
CSB-BP849087LPY1
CSB-MP849087LPY1
CSB-EP849087LPY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>